…
Avantium N.V., a chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands. It operates through Avantium R&D Solutions and Avantium Renewable Polymers. The company offers Releaf, boasts barrier properties for carbon dioxide and oxygen that leads to longer shelf life of packaged products used for packaging, textiles, film, and PEF applications. It also provides furandicarboxylic acid (FDCA), a building block for the high-performance plant-based polymer polyethylene furanoate (PEF). In addition, the company offers YXY Technology which catalytically converts plant-based sugars into FDCA. Further, it is development and commercialization of the Dawn Technology, Parana Technology, and Volta Technology. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Avantium develops renewable-chemicals and catalytic technologies centered on its YXY process to produce FDCA, a monomer for plant-based PEF as an alternative to PET. Long-term growth may be driven by demand for sustainable plastics, regulatory pressure on fossil polymers and potential licensing or offtake income from scaling its flagship plant, which could make it attractive to investors seeking exposure to bio-based materials.
Key risks are execution and financing of the commercial-scale ramp, limited operating history and revenues, uncertain technology adoption and reliance on offtake agreements and policy support.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -27.13M | -32.63M | -34.15M | -31.55M | -24.42M |
| Minority interest | 4.62M | 5.76M | 2.75M | 1.97M | - |
| Net income | -22.52M | -26.87M | -31.40M | -29.58M | -24.42M |
| Selling general administrative | 4.98M | 5.90M | 2.85M | 1.33M | 0.71M |
| Selling and marketing expenses | - | 1.83M | 1.98M | 1.33M | 0.71M |
| Gross profit | 10.19M | -30.57M | -25.30M | 14.06M | 7.88M |
| Reconciled depreciation | 4.14M | 5.20M | 7.40M | 8.14M | 7.84M |
| Ebit | - | -29.72M | -33.18M | -27.67M | -24.07M |
| Ebitda | - | -24.52M | -25.78M | -19.53M | -16.23M |
| Depreciation and amortization | - | 5.20M | 7.40M | 8.14M | 7.84M |
| Operating income | -43.03M | -44.70M | -34.85M | -27.67M | -24.07M |
| Other operating expenses | - | 65.73M | 54.55M | 44.09M | 34.84M |
| Interest expense | 2.22M | 2.90M | 0.14M | 0.60M | 0.35M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Interest income | 0.38M | 1.48M | 1.19M | 0.01M | 0.00M |
| Net interest income | -2.33M | -1.43M | 0.22M | -2.43M | -0.49M |
| Income tax expense | - | - | -2.75M | -1.97M | - |
| Total revenue | 14.59M | 21.04M | 19.70M | 17.83M | 10.92M |
| Total operating expenses | 57.63M | 14.12M | 9.55M | 40.32M | 31.80M |
| Cost of revenue | 4.41M | 51.61M | 45.00M | 3.77M | 3.04M |
| Total other income expense net | - | 12.07M | 0.70M | -3.88M | -0.35M |
| Net income from continuing ops | -27.13M | -32.63M | -34.15M | -31.55M | -24.42M |
| Net income applicable to common shares | - | - | - | -29.58M | -24.42M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 356.17M | 288.63M | 228.49M | 162.03M | 77.67M |
| Intangible assets | 2.94M | 3.27M | 2.32M | 1.98M | 1.84M |
| Other current assets | - | 3.33M | 11.16M | - | - |
| Total liab | 206.57M | 190.84M | 174.62M | 70.86M | 27.65M |
| Total stockholder equity | 149.60M | 95.85M | 46.17M | 81.13M | 50.03M |
| Other current liab | 4.75M | 20.50M | 35.65M | 23.34M | 12.23M |
| Common stock | - | 8.61M | 4.32M | 4.26M | 3.13M |
| Capital stock | 25.20M | 8.61M | 4.32M | 4.26M | 3.13M |
| Retained earnings | -285.23M | -262.91M | -236.08M | -206.75M | -195.29M |
| Other liab | - | - | - | 14.09M | - |
| Other assets | - | - | 0.00M | 15.25M | -0.00M |
| Cash | 55.83M | 23.90M | 33.72M | 58.37M | 33.41M |
| Total current liabilities | 146.63M | 171.13M | 52.73M | 33.87M | 18.55M |
| Current deferred revenue | - | 1.91M | 7.66M | 12.78M | - |
| Net debt | 90.21M | 125.28M | 75.11M | -33.57M | -22.71M |
| Short term debt | - | 133.95M | 2.12M | 1.90M | 1.60M |
| Short long term debt | 105.81M | 123.95M | - | - | - |
| Short long term debt total | - | 149.18M | 108.82M | 24.80M | 10.70M |
| Other stockholder equity | - | 341.76M | 277.93M | 283.61M | 242.19M |
| Property plant equipment | - | - | - | 70.34M | 32.80M |
| Total current assets | 68.11M | 42.38M | 54.27M | 74.47M | 43.04M |
| Net tangible assets | - | - | - | 79.15M | 48.19M |
| Short term investments | - | - | 1.50M | - | - |
| Net receivables | 3.49M | 13.83M | 6.52M | 2.48M | 6.52M |
| Long term debt | 40.24M | 7.52M | 99.20M | 12.86M | - |
| Inventory | 1.42M | 1.32M | 1.37M | 1.57M | 1.24M |
| Accounts payable | 15.61M | 14.77M | 12.13M | 8.63M | 4.71M |
| Accumulated other comprehensive income | - | 8.39M | 6.92M | - | - |
| Non currrent assets other | 0.19M | 0.19M | 0.00M | 15.25M | -0.00M |
| Non current assets total | 288.06M | 246.25M | 174.22M | 87.56M | 34.64M |
| Capital lease obligations | 8.53M | 10.12M | 9.62M | 11.94M | 10.70M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -58.63M | -89.77M | -23.40M | -3.93M |
| Change to liabilities | - | - | - | 18.73M | 1.43M |
| Total cashflows from investing activities | - | -58.63M | -89.77M | -23.40M | -3.93M |
| Net borrowings | 16.92M | 14.78M | 84.18M | 13.05M | -1.66M |
| Total cash from financing activities | - | 92.42M | 78.94M | 54.76M | 24.83M |
| Change to operating activities | - | - | - | 0.04M | 0.05M |
| Net income | -22.52M | -26.87M | -31.40M | -31.55M | -24.42M |
| Change in cash | 33.56M | -11.32M | -29.65M | 29.96M | 8.29M |
| Begin period cash flow | 23.90M | 35.22M | 64.87M | 34.91M | 26.63M |
| End period cash flow | 57.47M | 23.90M | 35.22M | 64.87M | 34.91M |
| Total cash from operating activities | -27.71M | -45.06M | -18.82M | -1.40M | -12.61M |
| Issuance of capital stock | 77.98M | 75.04M | 0.24M | 41.71M | 26.49M |
| Depreciation | 4.14M | 5.20M | 7.40M | 8.14M | 7.84M |
| Other cashflows from investing activities | - | -0.31M | -0.45M | -0.00M | -0.00M |
| Change to inventory | -0.10M | 0.05M | 0.20M | -0.33M | -0.01M |
| Change to account receivables | - | -1.26M | -5.54M | -1.42M | 0.46M |
| Other cashflows from financing activities | - | -2.39M | -3.21M | 13.05M | -1.66M |
| Change to netincome | - | - | - | - | 2.04M |
| Capital expenditures | 20.66M | 58.33M | 89.32M | 43.40M | 3.93M |
| Change in working capital | 7.39M | -5.65M | 8.38M | 17.02M | 1.92M |
| Stock based compensation | 0.59M | 1.45M | 1.11M | 0.81M | 1.71M |
| Other non cash items | 2.33M | -17.75M | 3.31M | 4.18M | 0.33M |
| Free cash flow | -48.37M | -103.39M | -108.14M | -44.80M | -16.54M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AVTXF Avantium N.V |
- -% |
5.64 | - | - | 13.84 | 1.07 | 19.29 | -6.06 |
| LIN Linde plc Ordinary Shares |
-8.17 1.57% |
511.55 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
0.02 0.05% |
40.75 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
3.63 1.82% |
203.13 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-11.50 3.26% |
340.87 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Avantium N.V., a chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands. It operates through Avantium R&D Solutions and Avantium Renewable Polymers. The company offers Releaf, boasts barrier properties for carbon dioxide and oxygen that leads to longer shelf life of packaged products used for packaging, textiles, film, and PEF applications. It also provides furandicarboxylic acid (FDCA), a building block for the high-performance plant-based polymer polyethylene furanoate (PEF). In addition, the company offers YXY Technology which catalytically converts plant-based sugars into FDCA. Further, it is development and commercialization of the Dawn Technology, Parana Technology, and Volta Technology. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.
| Name | Title | Year Born |
|---|---|---|
| Mr. Tom B. van Aken | CEO & Member of Management Board | 1970 |
| Mr. Bart Welten | CFO & Member of Management Board | 1960 |
| Mr. Gert-Jan M. Gruter | Chief Technology Officer | 1963 |
| Ms. Carmen Portocarero | Gen. Counsel | 1967 |
| Dominique Levant | Marketing & Communications Officer | NA |
| Mr. Alex Pérez de Santana | Director of Bus. Devel. | NA |
| Mr. Steven Olivier | Managing Director of R&D Solutions | 1964 |
| Mr. Bas Blom | Managing Director of the Renewable Polymers | 1964 |
| Mr. Boudewijn Van Schaïk | CFO & Member of the Management Board | 1979 |
| Ms. Carmen Portocarero | General Counsel | 1967 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.